High PRDX4 expression led to significantly decreased survival in non-stratified samples (p = 0.018) (Fig. 10J), and also in late stages (p = 0.00049) (Fig. 10K), this marker is associated with oxidative stress, conforming its associated with breast cancer progression and metastasis. Here, PRDX4 is linked to breast carcinoma.